Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Global University Venturing

Exits: February 1, 2022

A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.


Feb 1, 2022

Main Sequence masters another $105m

The CSIRO-linked venture firm has obtained additional capital from the Australian government less than a year after launching its second fund with an initial $194m.

Feb 1, 2022

Enable Injections exercises $215m series C

Ohio Innovation Fund was among the shareholders who returned for Enable Injections’ latest round.

Jan 31, 2022

Deals: January 31, 2022

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Jan 31, 2022

Exits: January 31, 2022

A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.

Jan 31, 2022

Exits: January 27, 2022

A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.

Jan 27, 2022

Deals: January 27, 2022

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Jan 27, 2022

Deals: January 24, 2022

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Jan 24, 2022

ImmPact Bio forges ahead with $111m

Advancing foundational research from UCLA and Migal – Galilee Research Institute, ImmPact is working on T-cell therapies for liquid and solid cancers.

Jan 21, 2022

Deals: January 21, 2022

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Jan 21, 2022

Deals: January 20, 2022

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Jan 20, 2022

Ori Biotech orchestrates series B

UCL spinout Ori Biotech has raised more than $100m in a series B round led by Novalis LifeSciences, just over a year after closing a $30m series A round.

Jan 20, 2022
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here